Literature DB >> 17345049

Study of cerebral cavernous malformation in Spain and Portugal: high prevalence of a 14 bp deletion in exon 5 of MGC4607 (CCM2 gene).

Lucía Ortiz1, Alzenira F Costa, María L Bellido, Francisca Solano, Jose M García-Moreno, Miguel A Gamero, Guillermo Izquierdo, Amal Chadli, Filipa Falcao, Jose Ferro, Javier Salas, Jose C Alvarez-Cermeño, Mariano Montori, María A Ramos-Arroyo, Alfredo Palomino, Elizabeth Pintado, Miguel Lucas.   

Abstract

OBJECTIVE: We aimed to study clinical, radiological and molecular genetic features of patients with cerebral cavernous malformations (CCMs) from the Iberian Peninsula.
METHODS: We screened Krit1(CCM1), MGC4607(CCM2), and PDCD10(CCM3) by systematic SSCP and direct sequencing of coding exons in 48 nuclear families and 30 sporadic cases of CCM from Spain and Portugal.
RESULTS: Screening of CCM patients detected nine different mutations in 19 families. We found four new mutations in Krit1. Three of them were caused by either a small insertion or deletion, which lead to frameshift and premature termination codons. We also found a missense L308H mutation located in a highly conserved sequence within the ankyrin domain of Krit1. In CCM2, we found a redundant 14 bp deletion in exon 5 of MGC4607 which predicts a truncated protein at residue 230. We did not find mutations in CCM3.
CONCLUSIONS: Finding that the 14 bp deletion was present in eleven families from the Iberian Peninsula indicates a high prevalence of this mutation. This redundant CCM2 mutation is worth considering in molecular diagnosis and genetic counselling of cerebral cavernous malformations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17345049     DOI: 10.1007/s00415-006-0359-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

1.  Spanish families with cerebral cavernous angioma do not bear 742C-->T Hispanic American mutation of the KRIT1 gene.

Authors:  M Lucas; F Solano; M D Zayas; J M García-Moreno; M A Gamero; A F Costa; G Izquierdo
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

2.  Spanish families with cavernous angiomas do not share the Hispano-American CCM1 haplotype.

Authors:  H H Jung; P Labauge; S Laberge; E Maréchal; E Tournier-Lasserve; M Lucas; J M Garcia-Moreno; M A Gamero; G Izquierdo; E Touriner-Lasserve
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-10       Impact factor: 10.154

3.  Krit1 missense mutations lead to splicing errors in cerebral cavernous malformation.

Authors:  Dominique J Verlaan; Adrian M Siegel; Guy A Rouleau
Journal:  Am J Hum Genet       Date:  2002-04-08       Impact factor: 11.025

4.  Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus.

Authors:  Christina L Liquori; Michel J Berg; Ferdinando Squitieri; Monica Ottenbacher; Marielle Sorlie; Tracey P Leedom; Milena Cannella; Vittorio Maglione; Louis Ptacek; Eric W Johnson; Douglas A Marchuk
Journal:  Hum Mutat       Date:  2006-01       Impact factor: 4.878

5.  Germline mutations in the CCM1 gene, encoding Krit1, cause cerebral cavernous malformations.

Authors:  M Lucas; A F Costa; M Montori; F Solano; M D Zayas; G Izquierdo
Journal:  Ann Neurol       Date:  2001-04       Impact factor: 10.422

6.  Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1).

Authors:  T Sahoo; E W Johnson; J W Thomas; P M Kuehl; T L Jones; C G Dokken; J W Touchman; C J Gallione; S Q Lee-Lin; B Kosofsky; J H Kurth; D N Louis; G Mettler; L Morrison; A Gil-Nagel; S S Rich; J M Zabramski; M S Boguski; E D Green; D A Marchuk
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

7.  CCM3 mutations are uncommon in cerebral cavernous malformations.

Authors:  D J Verlaan; J Roussel; S B Laurent; C E Elger; A M Siegel; G A Rouleau
Journal:  Neurology       Date:  2005-12-27       Impact factor: 9.910

8.  Mutations within the MGC4607 gene cause cerebral cavernous malformations.

Authors:  C Denier; S Goutagny; P Labauge; V Krivosic; M Arnoult; A Cousin; A L Benabid; J Comoy; P Frerebeau; B Gilbert; J P Houtteville; M Jan; F Lapierre; H Loiseau; P Menei; P Mercier; J J Moreau; A Nivelon-Chevallier; F Parker; A M Redondo; J M Scarabin; M Tremoulet; M Zerah; J Maciazek; E Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2004-01-22       Impact factor: 11.025

9.  Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27.

Authors:  H D Craig; M Günel; O Cepeda; E W Johnson; L Ptacek; G K Steinberg; C S Ogilvy; M J Berg; S C Crawford; R M Scott; E Steichen-Gersdorf; R Sabroe; C T Kennedy; G Mettler; M J Beis; A Fryer; I A Awad; R P Lifton
Journal:  Hum Mol Genet       Date:  1998-11       Impact factor: 6.150

10.  Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.

Authors:  Christina L Liquori; Michel J Berg; Adrian M Siegel; Elizabeth Huang; Jon S Zawistowski; T'Prien Stoffer; Dominique Verlaan; Fiyinfolu Balogun; Lori Hughes; Tracey P Leedom; Nicholas W Plummer; Milena Cannella; Vittorio Maglione; Ferdinando Squitieri; Eric W Johnson; Guy A Rouleau; Louis Ptacek; Douglas A Marchuk
Journal:  Am J Hum Genet       Date:  2003-11-17       Impact factor: 11.025

View more
  7 in total

1.  Cutaneous venous malformations related to KRIT1 mutation: case report and literature review.

Authors:  Francesca Romana Grippaudo; Maria Piane; Matteo Amoroso; Benedetto Longo; Silvana Penco; Luciana Chessa; Maria Giubettini; Fabio Santanelli
Journal:  J Mol Neurosci       Date:  2013-07-05       Impact factor: 3.444

2.  Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation.

Authors:  Christopher C Gibson; Weiquan Zhu; Chadwick T Davis; Jay A Bowman-Kirigin; Aubrey C Chan; Jing Ling; Ashley E Walker; Luca Goitre; Simona Delle Monache; Saverio Francesco Retta; Yan-Ting E Shiu; Allie H Grossmann; Kirk R Thomas; Anthony J Donato; Lisa A Lesniewski; Kevin J Whitehead; Dean Y Li
Journal:  Circulation       Date:  2014-12-08       Impact factor: 29.690

3.  Cerebral cavernous malformations: somatic mutations in vascular endothelial cells.

Authors:  Judith Gault; Issam A Awad; Peter Recksiek; Robert Shenkar; Robert Breeze; Michael Handler; Bette K Kleinschmidt-DeMasters
Journal:  Neurosurgery       Date:  2009-07       Impact factor: 4.654

4.  Varying clinical presentations of familial cerebral cavernous malformations (CCMs) and spinal cord cavernous malformations (SCCMs).

Authors:  Selena Nicholas-Bublick; Boyd M Koffman
Journal:  Radiol Case Rep       Date:  2015-12-07

5.  A Chinese Family With Cerebral Cavernous Malformation Caused by a Frameshift Mutation of the CCM1 Gene: A Case Report and Review of the Literature.

Authors:  Wenyu Liu; Ming Liu; Di Lu; Jiwei Wang; Zexin Cao; Xuchen Liu; Zichao Feng; Bin Huang; Xinyu Wang
Journal:  Front Neurol       Date:  2022-04-04       Impact factor: 4.086

6.  Mutation analysis of CCM1, CCM2 and CCM3 genes in a cohort of Italian patients with cerebral cavernous malformation.

Authors:  Rosalia D'Angelo; Valeria Marini; Carmela Rinaldi; Paola Origone; Alessandra Dorcaratto; Maria Avolio; Luca Goitre; Marco Forni; Valeria Capra; Concetta Alafaci; Cristina Mareni; Cecilia Garrè; Placido Bramanti; Antonina Sidoti; Saverio Francesco Retta; Aldo Amato
Journal:  Brain Pathol       Date:  2010-10-04       Impact factor: 6.508

7.  Mutation prevalence of cerebral cavernous malformation genes in Spanish patients.

Authors:  Rufino Mondéjar; Francisca Solano; Rocío Rubio; Mercedes Delgado; Angel Pérez-Sempere; Antonio González-Meneses; Teresa Vendrell; Guillermo Izquierdo; Amalia Martinez-Mir; Miguel Lucas
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.